W STRATEGIES, LLC for BIOGEN
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 4302: Protecting Access to Medicare Act of 2014. H.R. 4160: Keep the Promise to Seniors Act of 2014. CMS proposed rule affecting the Medicare Advantage and Medicare Prescription Drug Benefit (Part D) Programs, specifically as it relates to changes to the Part D programs, including coverage of therapeutic classes and non interference.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
S. 1720: Patent Transparency and Improvements Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2013. H.R. 3303: SOFTWARE Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.